{"transactions":[{"id":868345,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T18:47:28.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-26-007645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036126007645/form4.xml","form_type":"4"}},{"id":1081475,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T18:12:52.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027403","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036125027403/form4.xml","form_type":"4"}},{"id":1081474,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T18:12:52.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":56000,"derivative":{"exercise_price":5.87,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001140361-25-027403","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036125027403/form4.xml","form_type":"4"}},{"id":2060746,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-06T16:59:20.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 20,400 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027."}],"balance_after":20400,"derivative":{"exercise_price":11.61,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":20400},"source":{"system":"sec-edgar","filing":"0001140361-23-000827","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036123000827/form4.xml","form_type":"4"}},{"id":2245304,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-03T08:20:28.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. This option, representing a right to purchase a total of 150,000 shares of Common Stock, will become exercisable on June 2, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":4.22,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-22-021673","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036122021673/form4.xml","form_type":"4"}}]}